Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating heart disease via redirected T cell immunotherapies

Methods for treating heart disease via redirected T cell immunotherapies

US Patent 11786551 · Granted Oct 17, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Monoclonal antibody against canine fibroblast activation protein that cross-reac2024
Treatment of cancer using chimeric antigen receptor and protein kinase a blocker2024
Disrupting tumor tissues by targeting fibroblast activation protein (FAP)2024
Inhibition of diacylglycerol kinase to augment adoptive T cell transfer2024
Compositions and methods of enhancing anti-tumor response using hybrid neutrophi2024
Compositions and methods for targeting stromal cells for the treatment of cancer2023
Compositions and methods for targeting stromal cells for the treatment of cancer2023
Compositions and methods for targeting stromal cells for the treatment of cancer2019
Compositions and methods for targeting stromal cells for the treatment of cancer2019
Inhibition of diacylglycerol kinase to augment adoptive T cell transfer2018
Use of HDAC inhibitors for treatment of cardiac rhythm disorders2018
Compositions and methods for treating asthma and other lung diseases2017